Glycoprotein Hyposialylation Gives Rise to a Nephrotic-Like Syndrome That Is Prevented by Sialic Acid Administration in GNE V572L Point-Mutant Mice
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Mutations in the key enzyme of sialic acid biosynthesis, UDP-N-acetylglucosamine 2-epimerase/N-acetyl-mannosamine kinase, result in distal myopathy with rimmed vacuoles (DMRV)/hereditary inclusion body myopathy (HIBM) in humans. Sialic acid is an acidic monosaccharide that modifies non-reducing terminal carbohydrate chains on glycoproteins and glycolipids, and it plays an important role in cellular adhesions and interactions. In this study, we generated mice with a V572L point mutation in the GNE kinase domain. Unexpectedly, these mutant mice had no apparent myopathies or motor dysfunctions. However, they had a short lifespan and exhibited renal impairment with massive albuminuria. Histological analysis showed enlarged glomeruli with mesangial matrix deposition, leading to glomerulosclerosis and abnormal podocyte foot process morphologies in the kidneys. Glycan analysis using several lectins revealed glomerular epithelial cell hyposialylation, particularly the hyposialylation of podocalyxin, which is one of important molecules for the glomerular filtration barrier. Administering Neu5Ac to the mutant mice from embryonic stages significantly suppressed the albuminuria and renal pathology, and partially recovered the glomerular glycoprotein sialylation. These findings suggest that the nephrotic-like syndrome observed in these mutant mice resulted from impaired glomerular filtration due to the hyposialylation of podocyte glycoproteins, including podocalyxin. Furthermore, it was possible to prevent the nephrotic-like disease in these mice by beginning Neu5Ac treatment during gestation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426 · cited 1×
“Total RNA was extracted from mouse kidneys by the guanidine isothiocyanate method [33].”
MethodDerivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., & Roder, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8424 · Cited by 2,329 · cited 1×
“Chimeric mice generated by the aggregation method [28] were mated with C57BL/6 mice to confirm germ-line transmission.”
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P., Montgomery, C., Geske, R., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 2,016 · cited 1×
“A neo cassette [23] flanked by two loxP sites was inserted between the left and right arms for positive selection, and a DT-A cassette [24] was ligated at the end of the right arm for negative selection.”
Kestilä, M., Lenkkeri, U., Männikkö, M., Lamerdin, J., McCready, P., Putaala, H., Ruotsalainen, V., Morita, T., Nissinen, M., Herva, R., et al. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80057-x · Cited by 1,866 · cited 1×
“Children born with the Finnish type of CNS die within a few months after birth due to massive proteinuria caused by impaired podocyte function [17,36,37].”
Generation and Analysis of Interleukin-4 Deficient Mice
Kühn, R., Rajewsky, K., & Müller, W. (1991) · Science · doi:10.1126/science.1948049 · Cited by 1,248 · cited 1×
“The targeting vector was introduced into E14-1 ES cells (129/ Ola strain) [25] by electroporation, and G418-resistant colonies were picked up as described previously [26].”
MethodCongenital Nephrotic Syndrome in Mice Lacking CD2-Associated Protein
Shih, N.-Y., Li, J., Karpitskii, V., Nguyen, A., Dustin, M. L., Kanagawa, O., Miner, J. H., & Shaw, A. S. (1999) · Science · doi:10.1126/science.286.5438.312 · Cited by 861 · cited 1×
“losclerosis-like damage at nine months of age [17,22,38,39].”
Inclusion body myositis and myopathies
Griggs, R. C., Askanas, V., DiMauro, S., Engel, A., Karpati, G., Mendell, J. R., & Rowland, L. P. (1995) · Annals of Neurology · doi:10.1002/ana.410380504 · Cited by 837
The Neural Cell Adhesion Molecule (NCAM) as a Regulator of Cell-Cell Interactions
Rutishauser, U., Acheson, A., Hall, A. K., Mann, D. M., & Sunshine, J. (1988) · Science · doi:10.1126/science.3281256 · Cited by 787
Kanegae, Y., Lee, G., Sato, Y., Tanaka, M., Nakal, M., Sakaki, T., Sugano, S., & Saito, I. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.19.3816 · Cited by 606
Hereditary Proteinuria Syndromes and Mechanisms of Proteinuria
Tryggvason, K., Patrakka, J., & Wartiovaara, J. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052131 · Cited by 576 · cited 7×
“These features resemble CNS, a very rare type of nephrotic syndrome.”
Influential
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“For example, the heavily sialylated protein podocalyxin on glomerular podocyte foot processes (474) (475) (476) (477) (478) and heparan sulfate glycosaminoglycans within the glomerular basement membrane (479) (480) (481) (482) (483) (484) seem to play important roles in maintaining the integrity of blood plasma filtra…”
BackgroundGNE myopathy: current update and future therapy
Nishino, I., Carrillo-Carrasco, N., & Argov, Z. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-307051 · Cited by 165
Systemic Blockade of Sialylation in Mice with a Global Inhibitor of Sialyltransferases
Macauley, M. S., Arlian, B. M., Rillahan, C. D., Pang, P.-C., Bortell, N., Marcondes, M. C. G., Haslam, S. M., Dell, A., & Paulson, J. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.606517 · Cited by 129
Podocyte Pathology and Nephropathy – Sphingolipids in Glomerular Diseases
Merscher, S., & Fornoni, A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00127 · Cited by 129
“This phenotype was partially prevented by the administration of N -acetylneuraminic acid (Neu5Ac) to the mutant mice (51).”
BackgroundLopatina, O. L., Yoshihara, T., Nishimura, T., Zhong, J., Akther, S., Fakhrul, A. A. K. M., Liang, M., Higashida, C., Sumi, K., Furuhara, K., et al. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00133 · Cited by 119
“To investigate the motor coordination/motor learning abilities, the accelerating rota rod paradigm was used (Yoshihara et al., 2009; Ito et al., 2012).”
MethodSelf-citationCDG Therapies: From Bench to Bedside
Brasil, S., Pascoal, C., Francisco, R., Marques‐da‐Silva, D., Andreotti, G., Videira, P. A., Morava, É., Jaeken, J., & Ferreira, V. D. R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051304 · Cited by 117
“Despite the difficulties encountered in generating efficient in vivo models, advances have been made that have allowed a better understanding of the pathophysiological mechanisms underlying CDG and also the pre-clinical testing of compounds such as sialic acid (SA), [78,79], N-acetylmannosamine (ManNAc) [78,80–82], pe…”
BackgroundSialyllactose ameliorates myopathic phenotypes in symptomatic GNE myopathy model mice
Yonekawa, T., Malicdan, M. C. V., Cho, A., Hayashi, Y. K., Nonaka, I., Mine, T., Yamamoto, T., Nishino, I., & Noguchi, S. (2014) · Brain · doi:10.1093/brain/awu210 · Cited by 74
“…sialic acid level in kidney (Malicdan et al., 2012) also suggest that the other diseases associated with GNE gene mutation, such as severe renal disorders in Gne mutants (Galeano et al., 2007; Ito et al., 2012) and other transgenic models (Clement et al., 2011), would be treatable strategies.”
BackgroundGNE myopathy associated with congenital thrombocytopenia: A report of two siblings
Izumi, R., Niihori, T., Suzuki, N., Sasahara, Y., Rikiishi, T., Nishiyama, A., Nishiyama, S., Endo, K., Kato, M., Warita, H., et al. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2014.07.008 · Cited by 73
“The renal pathology including diffuse thickening of the glomerular basement membrane with the appearance of double contours is similar to those reported in GNE mutant mice [22,23], suggesting his nephritic phenotype is associated with GNE mutations.”
GNE myopathy: from clinics and genetics to pathology and research strategies
Pogoryelova, O., Coraspe, J. A. G., Nikolenko, N., Lochmüller, H., & Roos, A. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0802-x · Cited by 69
“In 2012, Ito and colleagues [67] further reported that renal pathology was based on hyposialylation of podocalyxin.”
BackgroundGenetic defects in the hexosamine and sialic acid biosynthesis pathway
Willems, A. P., van Engelen, B. G. M., & Lefeber, D. J. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.12.017 · Cited by 43
Grover, S., & Arya, R. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8604-6 · Cited by 38
Variable Phenotypes of Knockin Mice Carrying the M712T Gne Mutation
Sela, I., Yakovlev, L., Becker‐Cohen, M., Elbaz, M., Yanay, N., Shlomo, U. B., Yotvat, H., Fellig, Y., Argov, Z., & Mitrani‐Rosenbaum, S. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8209-7 · Cited by 34
“Very recently, a knockin mouse was generated with the exact same design as in the present study (Ito et al. 2012) introducing the mutation V572L.”
MethodGNE Myopathy and Cell Apoptosis: A Comparative Mutation Analysis
Singh, R., & Arya, R. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9191-5 · Cited by 35
New insights into the role of Jmjd3 and Utx in axial skeletal formation in mice
Naruse, C., Shibata, S., Tamura, M., Kawaguchi, T., Abe, K., Sugihara, K., Kato, T., Nishiuchi, T., Wakana, S., Ikawa, M., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201600642r · Cited by 27
“SDS-PAGE and Western blotting were performed as previously described (43).”
MethodSelf-citationPodocyte-Specific Sialylation-Deficient Mice Serve as a Model for Human FSGS
Niculovic, K. M., Blume, L., Wedekind, H., Kats, E., Albers, I., Groos, S., Abeln, M., Schmitz, J., Beuke, E., Bräsen, J. H., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018090951 · Cited by 26
Tavasoli, M., Li, L., Al-Momany, A., Zhu, L.-F., Adam, B., Wang, Z., & Ballermann, B. J. (2016) · Kidney International · doi:10.1016/j.kint.2016.01.001 · Cited by 24
Cosmc-dependent mucin-typeO-linked glycosylation is essential for podocyte function
Stotter, B. R., Talbot, B. E., Capen, D. E., Artelt, N., Zeng, J., Matsumoto, Y., Endlich, N., Cummings, R. D., & Schlöndorff, J. S. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00399.2019 · Cited by 26
A Rare Kidney Disease To Cure Them All? Towards Mechanism-Based Therapies for Proteinopathies
Dvela‐Levitt, M., Shaw, J. L., & Greka, A. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.11.008 · Cited by 22
Generation and characterization of a novel gne Knockout Model in Zebrafish
Livne, H., Avital, T., Ruppo, S., Harazi, A., Mitrani‐Rosenbaum, S., & Daya, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.976111 · Cited by 21
“The established mouse models are also difficult to interpret since they are either not reliable or do not present any muscle phenotype (Galeano et al., 2007; Malicdan et al., 2007; Ito et al., 2012; Sela et al., 2013; Benyamini et al., 2020).”
BackgroundPawluczyk, I. Z. A., Najafabadi, M. G., Patel, S. R., Desai, P., Vashi, D., Saleem, M. A., & Topham, P. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.10.017 · Cited by 21
Bosch-Morató, M., Iriondo, C., Guivernau, B., Valls-Comamala, V., Vidal, N., Olivé, M., Querfurth, H. W., & Muñoz, F. J. (2016) · Oncotarget · doi:10.18632/oncotarget.7997 · Cited by 21
“This supports the pharmacological therapeutic approaches based on sialic acid administration for GNE myopathy [50, 51].”
BackgroundDe Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20
Mitrani-Rosenbaum, S., Yakovlev, L., Becker‐Cohen, M., Argov, Z., Fellig, Y., & Harazi, A. (2021) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-210755 · Cited by 21
“Both the knocked in M743T [44,45] and V603L [46] mice died few days or weeks from severe renal failure.”
BackgroundSialic acid supplementation ameliorates puromycin aminonucleoside nephrosis in rats
Pawluczyk, I. Z. A., Najafabadi, M. G., Brown, J. R. G., Bevington, A., & Topham, P. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.78 · Cited by 16
Myogenesis defects in a patient-derived iPSC model of hereditary GNE myopathy
Schmitt, R. E., Smith, D. Y., Cho, D. S., Kirkeby, L. A., Resch, Z. T., Liewluck, T., Niu, Z., Milone, M., & Doles, J. D. (2022) · npj Regenerative Medicine · doi:10.1038/s41536-022-00238-3 · Cited by 17
“For example, some GNE models feature glomerulopathy, which is not found in GNE patients (Galeano et al., 2007; Kakani et al., 2012; Ito et al., 2012).”
Rationale and Design for a Phase 1 Study of N-Acetylmannosamine for Primary Glomerular Diseases
Huizing, M., Yardeni, T., Fuentes, F., Malicdan, M. C. V., Leoyklang, P., Volkov, A., Dekel, B., Brede, E., Blake, J. T., Powell, A., et al. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2019.06.012 · Cited by 15
Takagaki, S., Yamashita, R., Hashimoto, N., Sugihara, K., Kanari, K., Tabata, K., Nishie, T., Oka, S., Miyanishi, M., Naruse, C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-43551-6 · Cited by 14
Self-citationGopal, N., Koner, B. C., Bhattacharjee, A., & Bhat, V. (2016) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.174066 · Cited by 7
Pogoryelova, O., Urtizberea, J. A., Argov, Z., Nishino, I., Lochmüller, H., Urtizberea, J. A., Roos, A., Willems, A. P., Béhin, A., Udd, B., et al. (2019) · Neuromuscular Disorders · doi:10.1016/j.nmd.2019.02.010 · Cited by 7
Harazi, A., Yakovlev, L., Ilouz, N., Selke, P., Horstkorte, R., Fellig, Y., Lahat, O., Lifschytz, T., Abudi, N., Abramovitch, R., et al. (2024) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-240056 · Cited by 6
“Hyposialylationwasdetectedinthetwo knock-in mouse models [15–17] which had no appar-A ent muscle symptoms.”
BackgroundBiosynthetic and genetic pathways related to sialic acid metabolism
Huang, S., van de Ven, E. G. P., Tee, T., & Lefeber, D. J. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111262 · Cited by 6
“3] presented with renal abnormalities and had a short lifespan (224).”
Huang, L., Kondo, Y., Cao, L., Han, J., Li, T., Zuo, B., Yang, F., Yun, L., Ma, Z., Bai, X., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023011490 · Cited by 6
Tissue-specific isoform expression of GNE gene in human tissues
Awasthi, K., Bhattacharya, S., & Bhattacharya, A. (2022) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-022-09618-0 · Cited by 5
“Four mouse models expressing common human GNE mutations have been made so far (Malicdan et al. 2007; Galeano et al. 2007; Ito et al. 2012; Sela et al. 2013).”
BackgroundSpatial Glycomics and Kidney Disease
Veličković, D., & Anderton, C. (2024) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2025.151581 · Cited by 4
Various biological functions of carbohydrate chains learned from glycosyltransferase-deficient mice
Asano, M. (2020) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.20-0013 · Cited by 4
“These findings suggest that the nephrotic-like syndrome observed in these mutant mice resulted from impaired glomerular filtration due to the hyposialylation of podocyte glycoproteins, including podocalyxin [16].”
BackgroundSelf-citationArgov, Z., & Mitrani‐Rosenbaum, S. (2023) · Current clinical neurology · doi:10.1007/978-3-031-44009-0_9 · Cited by 3
Phase 1 Study of Oral N-Acetylmannosamine in Primary Podocytopathies
Huizing, M., Ganguli, A., Bolaños, J. A., Leoyklang, P., Wilkins, K. J., Zeng, Y. A., Figg, W. D., Rossignol, F., Malicdan, M. C. V., Kopp, J. B., et al. (2025) · Kidney International Reports · doi:10.1016/j.ekir.2025.103758 · Cited by 3
Background Strain and Natural Selection Improves Survival of HIBM Murine Model
Valles Ayoub., Y. (2012) · Molecular Biology · doi:10.4172/2168-9547.1000109
“Renal disorders were more severe in mice with the GneM712T pointmutation in comparison to those with the GneV572L point-mutation [13].”
MethodInfluentialMolecular Pathogenesis and Therapeutic Strategy in GNE Myopathy
Nishimura, H., & Noguchi, S. (2016) · Springer eBooks · doi:10.1007/978-4-431-55678-7_4
“Two mice strains with the recessive mutations of M712T and V572L (mutation nomenclature is based on GenBank NP_005467) represented the severe glomerular proteinuria without myopathic phenotype [18, 19].”
BackgroundUDP-GlcNAc 2-Epimerase/ManNAc Kinase (GNE)
Reutter, W. G., Hinderlich, S., & Kemmner, W. (2014) · Springer eBooks · doi:10.1007/978-4-431-54240-7_114
A abordagem metabolômica na indicação do tratamento de estenose de junção ureteropélvica em crianças
da Silva, L. H. F. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.46.2021.tde-11112021-115831 · Cited by 1
Minimal structural glyco-epitope for antibody recognition
Robakiewicz, S. (2020) · theses.fr (ABES) · doi:10.70675/72508b78zf24bz46f6zaf89zb1d4e7428c9d
Elsborg, S. H., Atay, J. C. L., Palmfeldt, J., Peters, C. D., Kjærgaard, K. D., Mutsaers, H. A. M., & Nørregaard, R. (2026) · Toxins · doi:10.3390/toxins18050225
“Neu5Ac is a key constituent of the glomerular filtration barrier [42], and elevated plasma levels have been reported in patients with glomerular kidney injury [43].”
Impaired Myogenic Differentiation Is a Shared Feature Across Genetic Myopathies
Soule, T., Slavin, M. B., Pontifex, C. S., Dabaja, M. Z., Melnyk, A., Dufour, A., Dumont, N. A., Shutt, T. E., & Pfeffer, G. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146338
Müller, P. M., Weilepp, L., Bork, K., Horstkorte, R., & Gesper, A. (2026) · Scientific Reports · doi:10.1038/s41598-026-66496-z
“The possibility of restoring the sialylation status of podocalyxin by ManNAc supplementation has already been demonstrated in mice that carried mutations in the Gne gene and therefore also had hyposialylated podocalyxin 28,29 .”
GNE Myopathy: 25 Years After Gene Identification—Facts, Controversies, Enigmas, Prospects
Mitrani‐Rosenbaum, S., & Argov, Z. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15176566
“As mentioned above, knock-in mice models [43–45] with homozygous mutations mimicking the human genotype, showed an early kidney disease but no muscle phenotype pathology.”
Urinary metabolomics profile in children with ureteropelvic junction obstruction
da Silva, L. H. F., Mello, M. F., Kataoka, F. G. H., Filho, U. F. A., Farah, J. P. S., Yamaguchi, L. F., Kato, M. J., de Oliveira, M. A. L., Faccio, A. T., Andrade, L., et al. (2026) · Metabolomics · doi:10.1007/s11306-026-02527-0
“Mice with pro - teinuria and podocytopathy had a good response to treat-ment when N -acetyl-D-mannosamine supplementation was administered (Huizing et al., 2019, Ito et al., 2012).”
Metadata
- Authors
- Ito, M., Sugihara, K., Asaka, T., Toyama, T., Yoshihara, T., Furuichi, K., Wada, T., & Asano, M.
- Affiliations
- Kanazawa University (JP)
- Nanao hospital (JP)
- Corresponding author
- Asano, Masahide
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-01-13
- Volume
- 7
- Issue
- 1
- Pages
- e29873
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3258264
- OpenAlex
- W2033597553
- Cited by
- 47
- References
- 48
- Citations by year
- 2026: 6 · 2025: 1 · 2024: 3 · 2023: 1 · 2022: 4 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 2 · 2017: 1 · 2016: 5 · 2015: 3 · 2014: 8 · 2013: 1 · 2012: 2
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Kanazawa University
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science (24406028, 23700509, 23650232, 22300142, 19300144, 23500493, 22590883)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- sialic acid biosynthesis, sialic acid deficiency, glycoprotein hyposialylation, nephrotic syndrome, podocalyxin, glomerular filtration barrier, albuminuria, glomerulosclerosis, podocytes, hereditary inclusion body myopathy, distal myopathy with rimmed vacuoles, mouse model
- MeSH terms
- Albuminuria, Animals, Base Sequence, Carbohydrate Epimerases, Molecular Sequence Data, Nephrotic Syndrome, Polysaccharides, Sialoglycoproteins, Staining and Labeling, Blotting, Western, Point Mutation, N-Acetylneuraminic Acid, Lectins, Podocytes, Mice, Biosynthetic Pathways, Cystatin C
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.